FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000628732> ?p ?o ?g. }

• W2000628732 endingPage "202" @default.
• W2000628732 startingPage "191" @default.
• W2000628732 abstract "Binding sites were solubilized from human placental membrane using 1.5% sodium cholate and were assayed using polyethylene glycol precipitation. These soluble binding sites had properties of an adenosine A1 binding site. 2-[3H]Chloroadenosine and N-[3H]-ethylcarboxamidoadenosine (NECA) binding were time dependent and reversible. Scatchard plots indicate two classes of binding sites with Kd values of 6 and 357 nM for 2-chloro[8-3H]adenosine and 0.1 and 26 nM with [3H]NECA. The specificity of [3H]NECA binding was assessed by the ability of adenosine analogs to complete for binding sites. Using this approach the estimated IC50 values were 60 nM for (R-PIA), 160 nM for S-PIA, 80 nM for NECA, and 20 nM for 2-chloroadenosine. Binding of [3H]NECA to the soluble sites is inhibited to 48% of the control value by 100 microM guanylyl-5'-imidodiphosphate (Gpp(NH)p). The IC50 value for NECA binding to the soluble binding site was increased from 80 nM to 1500 by Gpp(NH)p. There was a shift of binding affinity from a mixture of high and low affinity to only low affinity with 100 microM Gpp(NH)p. Despite these alterations a NECA prelabeled molecular species of 150 kDa did not decrease in molecular weight upon the addition of 100 microM Gpp(NH)p during high-performance liquid chromatography on a Superose 12 column. Other evidence to support the concept of preferential solubilization and assay of a small population of A1 binding sites was obtained. Following solubilization adenosine A2-like binding sites could be detected only in reconstituted vesicles. The existence of small amounts of A1 binding sites in intact human placental membranes was directly demonstrated using the A1 agonist ligand N6-[3H]cyclohexyladenosine and the A1 antagonist ligand 8-[3H]cyclopentyl-1,3-dipropylxanthine. JAR choriocarcinoma cells have A2-like membrane binding sites. In contrast to placental membranes, only A2-like binding sites could be solubilized from JAR choriocarcinoma cells. These observations indicate that human placental membranes contain adenosine A1 binding sites in addition to A2-like binding sites. These sites are guanine nucleotide sensitive, but do not shift to a lower molecular weight form upon assumption of a low affinity state." @default.
• W2000628732 created "2016-06-24" @default.
• W2000628732 creator A5003275480 @default.
• W2000628732 creator A5004393951 @default.
• W2000628732 creator A5005403102 @default.
• W2000628732 creator A5079325280 @default.
• W2000628732 creator A5090701680 @default.
• W2000628732 date "1989-01-01" @default.
• W2000628732 modified "2023-10-16" @default.
• W2000628732 title "Characteristics of an adenosine A1 binding site in human placental membranes" @default.
• W2000628732 cites W1493883487 @default.
• W2000628732 cites W1506025441 @default.
• W2000628732 cites W1516153383 @default.
• W2000628732 cites W1523802068 @default.
• W2000628732 cites W1540869004 @default.
• W2000628732 cites W1629566464 @default.
• W2000628732 cites W1658992953 @default.
• W2000628732 cites W1702339793 @default.
• W2000628732 cites W19684891 @default.
• W2000628732 cites W1970418444 @default.
• W2000628732 cites W1983649348 @default.
• W2000628732 cites W1984128196 @default.
• W2000628732 cites W1997052349 @default.
• W2000628732 cites W2011096544 @default.
• W2000628732 cites W2011596802 @default.
• W2000628732 cites W2024003911 @default.
• W2000628732 cites W2039849556 @default.
• W2000628732 cites W2043813981 @default.
• W2000628732 cites W2049790354 @default.
• W2000628732 cites W2072139775 @default.
• W2000628732 cites W2074631079 @default.
• W2000628732 cites W2077765096 @default.
• W2000628732 cites W2079114945 @default.
• W2000628732 cites W2084603445 @default.
• W2000628732 cites W2090454128 @default.
• W2000628732 cites W2095378950 @default.
• W2000628732 cites W2096891871 @default.
• W2000628732 cites W2119263245 @default.
• W2000628732 cites W2125788939 @default.
• W2000628732 cites W2172509713 @default.
• W2000628732 cites W2319382189 @default.
• W2000628732 cites W2331486720 @default.
• W2000628732 cites W4293247451 @default.
• W2000628732 doi "https://doi.org/10.1016/0003-9861(89)90579-1" @default.
• W2000628732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2912375" @default.
• W2000628732 hasPublicationYear "1989" @default.
• W2000628732 type Work @default.
• W2000628732 sameAs 2000628732 @default.
• W2000628732 citedByCount "12" @default.
• W2000628732 crossrefType "journal-article" @default.
• W2000628732 hasAuthorship W2000628732A5003275480 @default.
• W2000628732 hasAuthorship W2000628732A5004393951 @default.
• W2000628732 hasAuthorship W2000628732A5005403102 @default.
• W2000628732 hasAuthorship W2000628732A5079325280 @default.
• W2000628732 hasAuthorship W2000628732A5090701680 @default.
• W2000628732 hasBestOaLocation W20006287322 @default.
• W2000628732 hasConcept C107824862 @default.
• W2000628732 hasConcept C12554922 @default.
• W2000628732 hasConcept C144024400 @default.
• W2000628732 hasConcept C149923435 @default.
• W2000628732 hasConcept C170493617 @default.
• W2000628732 hasConcept C185592680 @default.
• W2000628732 hasConcept C202751555 @default.
• W2000628732 hasConcept C2776964284 @default.
• W2000628732 hasConcept C2776991684 @default.
• W2000628732 hasConcept C2777752497 @default.
• W2000628732 hasConcept C2778938600 @default.
• W2000628732 hasConcept C2908647359 @default.
• W2000628732 hasConcept C41625074 @default.
• W2000628732 hasConcept C43617362 @default.
• W2000628732 hasConcept C55493867 @default.
• W2000628732 hasConcept C67907053 @default.
• W2000628732 hasConcept C71240020 @default.
• W2000628732 hasConcept C86803240 @default.
• W2000628732 hasConceptScore W2000628732C107824862 @default.
• W2000628732 hasConceptScore W2000628732C12554922 @default.
• W2000628732 hasConceptScore W2000628732C144024400 @default.
• W2000628732 hasConceptScore W2000628732C149923435 @default.
• W2000628732 hasConceptScore W2000628732C170493617 @default.
• W2000628732 hasConceptScore W2000628732C185592680 @default.
• W2000628732 hasConceptScore W2000628732C202751555 @default.
• W2000628732 hasConceptScore W2000628732C2776964284 @default.
• W2000628732 hasConceptScore W2000628732C2776991684 @default.
• W2000628732 hasConceptScore W2000628732C2777752497 @default.
• W2000628732 hasConceptScore W2000628732C2778938600 @default.
• W2000628732 hasConceptScore W2000628732C2908647359 @default.
• W2000628732 hasConceptScore W2000628732C41625074 @default.
• W2000628732 hasConceptScore W2000628732C43617362 @default.
• W2000628732 hasConceptScore W2000628732C55493867 @default.
• W2000628732 hasConceptScore W2000628732C67907053 @default.
• W2000628732 hasConceptScore W2000628732C71240020 @default.
• W2000628732 hasConceptScore W2000628732C86803240 @default.
• W2000628732 hasIssue "1" @default.
• W2000628732 hasLocation W20006287321 @default.
• W2000628732 hasLocation W20006287322 @default.
• W2000628732 hasLocation W20006287323 @default.
• W2000628732 hasOpenAccess W2000628732 @default.
• W2000628732 hasPrimaryLocation W20006287321 @default.

• next